Berlin - The drug supply in the statutory health insurance (GKV) is increasingly characterized by discount contracts. This emerges from figures from the market research institute. According to this, in September 2009 pharmacies sold 23.4 million packs of “discounted” drugs in the generic SHI market. The discount rate in this market segment thus reached 69.4 percent. The corresponding sales in the total statutory health insurance market amounted to 43.1 percent.
Against this background, the industry association complains that it was primarily the generics manufacturers who financed the discount agreements. "Of all the companies that permanently relieve the GKV with their low list prices anyway have to finance the discounts associated with the discount contracts from their revenues," criticizes the association.